
Lam Research (LRCX) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
5.2B
Gross Profit
2.6B
50.08%
Operating Income
1.7B
33.67%
Net Income
1.7B
33.26%
Balance Sheet Metrics
Total Assets
21.3B
Total Liabilities
11.5B
Shareholders Equity
9.9B
Debt to Equity
1.16
Cash Flow Metrics
Operating Cash Flow
1.8B
Free Cash Flow
2.4B
Revenue & Profitability Trend
Lam Research Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 18.4B | 14.9B | 17.4B | 17.2B | 14.6B |
Cost of Goods Sold | 9.5B | 7.9B | 9.7B | 9.4B | 7.8B |
Gross Profit | 9.0B | 7.1B | 7.8B | 7.9B | 6.8B |
Gross Margin % | 48.7% | 47.3% | 44.6% | 45.7% | 46.5% |
Operating Expenses | |||||
Research & Development | 2.1B | 1.9B | 1.7B | 1.6B | 1.5B |
Selling, General & Administrative | 981.7M | 868.2M | 832.8M | 885.7M | 829.9M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 3.1B | 2.8B | 2.6B | 2.5B | 2.3B |
Operating Income | 5.9B | 4.3B | 5.2B | 5.4B | 4.5B |
Operating Margin % | 32.0% | 28.7% | 29.9% | 31.2% | 30.6% |
Non-Operating Items | |||||
Interest Income | 231.3M | 251.9M | 139.0M | 15.2M | 19.7M |
Interest Expense | 178.2M | 185.2M | 186.5M | 184.8M | 208.6M |
Other Non-Operating Income | 4.0M | 11.4M | -60.3M | -19.2M | 77.7M |
Pre-tax Income | 6.0B | 4.4B | 5.1B | 5.2B | 4.4B |
Income Tax | 599.9M | 532.4M | 598.3M | 587.8M | 462.3M |
Effective Tax Rate % | 10.1% | 12.2% | 11.7% | 11.3% | 10.6% |
Net Income | 5.4B | 3.8B | 4.5B | 4.6B | 3.9B |
Net Margin % | 29.1% | 25.7% | 25.9% | 26.7% | 26.7% |
Key Metrics | |||||
EBITDA | 6.5B | 4.9B | 5.7B | 5.8B | 4.8B |
EPS (Basic) | $4.17 | $2.91 | $3.33 | $3.29 | $2.72 |
EPS (Diluted) | $4.15 | $2.90 | $3.32 | $3.28 | $2.69 |
Basic Shares Outstanding | 1286101000 | 1314100000 | 1354720000 | 1398990000 | 1436090000 |
Diluted Shares Outstanding | 1286101000 | 1314100000 | 1354720000 | 1398990000 | 1436090000 |
Income Statement Trend
Lam Research Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 6.4B | 5.8B | 5.3B | 3.5B | 4.4B |
Short-term Investments | - | - | 37.6M | 135.7M | 1.3B |
Accounts Receivable | 3.4B | 2.5B | 2.8B | 4.3B | 3.0B |
Inventory | 4.3B | 4.2B | 4.8B | 4.0B | 2.7B |
Other Current Assets | 440.3M | 298.2M | 251.8M | 347.4M | 207.5M |
Total Current Assets | 14.5B | 12.9B | 13.2B | 12.3B | 11.7B |
Non-Current Assets | |||||
Property, Plant & Equipment | 23.2M | 24.5M | 53.7M | 42.2M | 44.1M |
Goodwill | 3.4B | 3.4B | 3.4B | 3.1B | 3.1B |
Intangible Assets | 182.2M | 138.5M | 168.5M | 101.8M | 132.4M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 2.6B | 1.9B | 1.9B | 1.6B | 1.3B |
Total Non-Current Assets | 6.8B | 5.9B | 5.6B | 4.9B | 4.2B |
Total Assets | 21.3B | 18.7B | 18.8B | 17.2B | 15.9B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 854.2M | 614.0M | 470.7M | 1.0B | 829.7M |
Short-term Debt | 754.3M | 504.8M | 8.4M | 7.4M | 11.3M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 693.8M | 609.5M | 580.6M | 589.7M | 456.9M |
Total Current Liabilities | 6.6B | 4.3B | 4.2B | 4.6B | 3.5B |
Non-Current Liabilities | |||||
Long-term Debt | 3.7B | 4.5B | 5.0B | 5.0B | 5.0B |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | 581.6M | 575.0M | 501.3M | 422.9M | 398.7M |
Total Non-Current Liabilities | 4.9B | 5.9B | 6.4B | 6.4B | 6.3B |
Total Liabilities | 11.5B | 10.2B | 10.6B | 10.9B | 9.9B |
Equity | |||||
Common Stock | 1.3M | 130.0K | 133.0K | 137.0K | 143.0K |
Retained Earnings | 29.0B | 24.8B | 22.0B | 18.5B | 14.7B |
Treasury Stock | 27.8B | 24.4B | 21.5B | 19.5B | 15.6B |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 9.9B | 8.5B | 8.2B | 6.3B | 6.0B |
Key Metrics | |||||
Total Debt | 4.5B | 5.0B | 5.0B | 5.0B | 5.0B |
Working Capital | 7.9B | 8.5B | 9.0B | 7.7B | 8.1B |
Balance Sheet Composition
Lam Research Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 5.4B | 3.8B | 4.5B | 4.6B | 3.9B |
Depreciation & Amortization | 386.3M | 359.7M | 342.4M | 333.7M | 307.2M |
Stock-Based Compensation | 343.4M | 293.1M | 286.6M | 259.1M | 220.2M |
Working Capital Changes | 320.3M | 680.7M | 131.6M | -1.9B | -1.0B |
Operating Cash Flow | 6.1B | 5.0B | 5.2B | 3.0B | 3.2B |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Acquisitions | 0 | 0 | -120.0M | 0 | 0 |
Investment Purchases | - | 0 | 0 | -567.8M | -3.4B |
Investment Sales | 0 | 37.8M | 98.1M | 1.7B | 3.9B |
Investing Cash Flow | 51.1M | 26.1M | -33.0M | 1.2B | 422.4M |
Financing Activities | |||||
Share Repurchases | -3.4B | -2.8B | -2.0B | -3.9B | -2.7B |
Dividends Paid | -1.1B | -1.0B | -907.9M | -815.3M | -727.0M |
Debt Issuance | - | - | - | 0 | 0 |
Debt Repayment | -507.5M | -256.1M | -23.2M | -11.9M | -862.1M |
Financing Cash Flow | -5.1B | -4.1B | -2.9B | -4.7B | -4.3B |
Free Cash Flow | 5.4B | 4.3B | 4.7B | 2.6B | 3.2B |
Net Change in Cash | 1.0B | 882.7M | 2.2B | -499.5M | -604.4M |
Cash Flow Trend
Lam Research Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
23.82
Forward P/E
23.15
Price to Book
12.72
Price to Sales
6.79
PEG Ratio
23.15
Profitability Ratios
Profit Margin
29.07%
Operating Margin
33.67%
Return on Equity
58.24%
Return on Assets
18.40%
Financial Health
Current Ratio
2.21
Debt to Equity
48.23
Beta
1.66
Per Share Data
EPS (TTM)
$4.15
Book Value per Share
$7.77
Revenue per Share
$14.33
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
lrcx | 125.1B | 23.82 | 12.72 | 58.24% | 29.07% | 48.23 |
Applied Materials | 131.7B | 19.59 | 6.72 | 35.63% | 23.88% | 32.11 |
KLA | 115.6B | 28.82 | 24.65 | 100.78% | 33.41% | 129.75 |
Teradyne | 17.6B | 38.41 | 6.21 | 16.85% | 16.59% | 2.62 |
Entegris | 11.9B | 40.21 | 3.12 | 8.08% | 9.17% | 106.49 |
Nova | 7.3B | 33.88 | 6.69 | 24.23% | 29.10% | 19.08 |
Financial data is updated regularly. All figures are in the company's reporting currency.